These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7047748)

  • 1. Autoantibodies to fibroblasts in scleroderma.
    Brentnall TJ; Kenneally D; Barnett AJ; de Aizpurua HJ; Lolait SJ; Ashcroft R; Toh BH
    J Clin Lab Immunol; 1982 May; 8(1):9-12. PubMed ID: 7047748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinucleolar autoantibodies demonstrated by monolayers of human fibroblasts in sera from patients with systemic lupus erythematosus, progressive systemic sclerosis and chronic active hepatitis.
    Kenneally D; Mackay IR; Toh BH
    J Clin Lab Immunol; 1984 May; 14(1):13-6. PubMed ID: 6748043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nucleolar, homogeneous and peripheral fluorescence of epidermal nuclei in direct immunofluorescence: 4 cases (author's transl)].
    Morel P; Allègre P; Civatte J
    Ann Dermatol Venereol; 1979 Apr; 106(4):361-4. PubMed ID: 384881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The PM-Scl (polymyositis-scleroderma) autoantibody and its nucleolar fluorescence pattern].
    Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski TP; Jablonska S
    Dermatol Monatsschr; 1989; 175(8):479-83. PubMed ID: 2676628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast monolayers as substrates for the demonstration and analysis of anti-nuclear autoantibodies.
    Kenneally D; Lolait SJ; Toh BH
    J Clin Lab Immunol; 1983 Jan; 10(1):47-51. PubMed ID: 6338237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.
    Kallenberg CG; de Jong MC; Walstra TM; Kardaun S; The TH
    J Rheumatol; 1983 Oct; 10(5):733-40. PubMed ID: 6606041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic characterization of autoreactivity to nuclear antigens in patients with systemic lupus erythematosus].
    Lenert P; Felle D; Lenert G; Mitić I; Curić S; Vodopivec S; Tepavcević P
    Med Pregl; 1993; 46(5-6):167-72. PubMed ID: 7869968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing HEp-2 cell line with rat liver in routine screening test for antinuclear and antinucleolar autoantibodies in autoimmune diseases.
    Prost AC; Abuaf N; Rouquette-Gally AM; Homberg JC; Combrisson A
    Ann Biol Clin (Paris); 1987; 45(6):610-7. PubMed ID: 3326434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex.
    Yang JM; Hildebrandt B; Luderschmidt C; Pollard KM
    Arthritis Rheum; 2003 Jan; 48(1):210-7. PubMed ID: 12528121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies in sera of Thai patients with Plasmodium falciparum infection.
    Boonpucknavig S; Ekapanyakul G
    Clin Exp Immunol; 1984 Oct; 58(1):77-82. PubMed ID: 6383670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoimmunity in patients with bronchogenic carcinomas: occurrence of antibodies against nuclear antigens, chromosomes and ds-deoxyribonucleic acid].
    Dellen H; Seemayer NH
    Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Sep; 177(6):451-68. PubMed ID: 6322478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The fibrillarin (Scl-34) autoantibody in systemic scleroderma].
    Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Chorzelski TP; Jablonska S
    Dermatol Monatsschr; 1990; 176(1):19-26. PubMed ID: 2178987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against calpastatin in sera from patients with systemic sclerosis.
    Sato S; Hasegawa M; Nagaoka T; Takamatsu Y; Yazawa N; Ihn H; Kikuchi K; Takehara K
    J Rheumatol; 1998 Nov; 25(11):2135-9. PubMed ID: 9818655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to nucleolar antigens in systemic scleroderma: clinical correlations.
    Błaszczyk M; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski T; Kołacińska-Strasz Z; Beutner EH; Kumar V
    Br J Dermatol; 1990 Oct; 123(4):421-30. PubMed ID: 2128868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinuclear antibodies as immunologic markers for a benign subset and different clinical characteristics of scleroderma.
    Kleinsmith DM; Heinzerling RH; Burnham TK
    Arch Dermatol; 1982 Nov; 118(11):882-5. PubMed ID: 6753766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of antinuclear antibodies in progressive systemic sclerosis].
    Scagliusi P; De Lucia M; Di Luca ML; Pannarale M; Pipitone V
    Minerva Med; 1984 Feb; 75(5):161-6. PubMed ID: 6366619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly conserved 72,000 dalton centromeric antigen reactive with autoantibodies from patients with progressive systemic sclerosis.
    McNeilage LJ; Whittingham S; McHugh N; Barnett AJ
    J Immunol; 1986 Oct; 137(8):2541-7. PubMed ID: 3531335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.
    Bunn CC; Denton CP; Shi-Wen X; Knight C; Black CM
    Br J Rheumatol; 1998 Jan; 37(1):15-20. PubMed ID: 9487245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct immunofluorescent findings in scleroderma syndromes.
    Connolly SM; Winkelmann RK
    Acta Derm Venereol; 1981; 61(1):29-36. PubMed ID: 6164211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.